BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24401270)

  • 1. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.
    Gutierrez A; Pan L; Groen RW; Baleydier F; Kentsis A; Marineau J; Grebliunaite R; Kozakewich E; Reed C; Pflumio F; Poglio S; Uzan B; Clemons P; VerPlank L; An F; Burbank J; Norton S; Tolliday N; Steen H; Weng AP; Yuan H; Bradner JE; Mitsiades C; Look AT; Aster JC
    J Clin Invest; 2014 Feb; 124(2):644-55. PubMed ID: 24401270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
    Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
    J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PP2A by perphenazine induces apoptosis in T-ALL.
    Cancer Discov; 2014 Mar; 4(3):OF14. PubMed ID: 24596208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effects of perphenazine on canine lymphoma.
    Tsuji S; Yabe R; Usui T; Mizuno T; Ohama T; Sato K
    J Vet Med Sci; 2016 Sep; 78(8):1293-8. PubMed ID: 27150024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.
    Morita K; He S; Nowak RP; Wang J; Zimmerman MW; Fu C; Durbin AD; Martel MW; Prutsch N; Gray NS; Fischer ES; Look AT
    Cell; 2020 Apr; 181(3):702-715.e20. PubMed ID: 32315619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
    Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
    Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.
    Richard NP; Pippa R; Cleary MM; Puri A; Tibbitts D; Mahmood S; Christensen DJ; Jeng S; McWeeney S; Look AT; Chang BH; Tyner JW; Vitek MP; Odero MD; Sears R; Agarwal A
    Oncotarget; 2016 Dec; 7(51):84214-84227. PubMed ID: 27705940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
    Liu L; Huang Z; Chen J; Wang J; Wang S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):142. PubMed ID: 29986744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
    Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
    Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
    Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
    Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2A has an essential role in promoting thymocyte survival during selection.
    Zheng M; Li D; Zhao Z; Shytikov D; Xu Q; Jin X; Liang J; Lou J; Wu S; Wang L; Hu H; Zhou Y; Gao X; Lu L
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12422-12427. PubMed ID: 31152132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
    Aster JC; Bodnar N; Xu L; Karnell F; Milholland JM; Maillard I; Histen G; Nam Y; Blacklow SC; Pear WS
    PLoS One; 2011; 6(10):e25645. PubMed ID: 22022427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
    Etchin J; Sanda T; Mansour MR; Kentsis A; Montero J; Le BT; Christie AL; McCauley D; Rodig SJ; Kauffman M; Shacham S; Stone R; Letai A; Kung AL; Thomas Look A
    Br J Haematol; 2013 Apr; 161(1):117-27. PubMed ID: 23373539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
    Farrington CC; Yuan E; Mazhar S; Izadmehr S; Hurst L; Allen-Petersen BL; Janghorban M; Chung E; Wolczanski G; Galsky M; Sears R; Sangodkar J; Narla G
    J Biol Chem; 2020 Jan; 295(3):757-770. PubMed ID: 31822503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
    Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
    Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT; Conrad DM; Hoskin DW
    Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.